PAIN TRIGGERS
Intense fear of weight gain prevents or complicates seeking necessary treatment for depression.
Polypharmacy combinations fail to fully resolve symptoms, leaving the patient feeling unlike themselves.
SaaS· ADHD patientsPain 8.00/10WTP 6.0/10Market 8.0/10Validation 7.0Confidence 85%Oct 9, 2026
PsychStack: Aggregated Side-Effect Insights for Psychiatric Polypharmacy
Patients lack personalized data on how specific, complex combinations of psychiatric medications will affect their weight, mood, and energy, leading them to delay care or rely on unverified forum anecdotes.
analyticscrowdsourcingdata-managementhealthcaremobile-apppatientssaas
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Patients managing multiple mental health conditions struggle to find effective medication combinations without triggering severe side effects like weight gain, leading to treatment hesitancy and anxiety.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Vyvanse, Wellbutrin & Sertraline Experiences
ADHD14
Vyvanse, Wellbutrin & Sertraline Experiences
ADHD14
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD patientsPsychiatric Polypharmacy Patients
Individuals taking multiple medications for comorbid conditions (like ADHD, depression, and anxiety) who are highly anxious about severe side effects like weight gain.
Context
Find anecdotal evidence and reassurance from others regarding the efficacy and side effects (specifically weight gain) of a highly specific psychiatric medication combination.
Delaying necessary mental health interventions to avoid feared physical side effects.
Specifically requesting medications known for favorable side-effect profiles rather than their primary efficacy.
Current Workarounds
Delaying necessary treatment out of fear of side effects
Crowdsourcing anecdotal medical experiences on Reddit
Guessing if stimulants will counteract antidepressant weight gain
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Standard psychiatric medications often have unacceptable side effect profiles (like weight gain) that deter patients from timely intervention.
There is a lack of accessible, personalized clinical data on how complex multi-drug combinations interact to affect body weight and energy levels.
Patients are left to trial-and-error polypharmacy, having to guess if one stimulant or anti-depressant will 'combat' the side effects of another.
OPPORTUNITY & VALUE
Why Now
Repeated mentions of terror of weight gain as a barrier to care and reliance on online forums to validate polypharmacy effects.
Value Proposition
Focuses strictly on multi-drug combinations (polypharmacy) and highly feared side effects (weight gain) rather than generic single-drug WebMD profiles.
Product Direction
A crowdsourced database and tracking app where users can look up highly specific medication stacks (e.g., Vyvanse + Wellbutrin + Sertraline) to see statistically aggregated patient reports on side effects, particularly weight gain and fatigue.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$8/moConsumer subscription for advanced stack insights
Model
Freemium SaaS
WILLINGNESS TO PAY
Patients are deeply distressed and delaying critical medical care due to side effect anxiety. Access to structured reassurance and data is easily worth a low monthly fee during the high-anxiety medication adjustment phase.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Find out how your exact medication stack affects people just like you.”
A crowdsourced database and tracking app where users can look up highly specific medication stacks (e.g., Vyvanse + Wellbutrin + Sertraline) to see statistically aggregated patient reports on side effects, particularly weight gain and fatigue.
Core Features
Medication stack lookup tool for up to 5 concurrent drugs
Aggregated side-effect charts focused on weight, energy, and mood
Anonymous structured contribution form for a user's current stack
Weekly Roadmap
1
W1-W2
Database schema and core contribution flow established.
- •Build medication auto-complete database
- •Create anonymous side-effect reporting form
- •Set up secure database architecture
2
W3-W4
Stack search and data visualization functional.
- •Develop search interface for multi-drug queries
- •Build aggregated charts for weight and mood changes
- •Implement basic demographic filtering
3
W5
Initial dataset seeded and beta testing underway.
- •Seed database with initial open-source/consented data
- •Recruit 50 beta testers from Reddit communities
- •Implement strict legal/medical disclaimers across the UI
4
W6
Public launch and monetization enabled.
- •Integrate Stripe for premium tier access
- •Launch in patient advocacy groups
- •Track first active user searches and conversions
Launch Strategy
Launch directly into highly engaged patient communities like r/ADHD, r/depression, and r/bipolar after seeding the database with initial consented self-reports.
RISKS & ASSUMPTIONS
Top Risks
Medical Liability Risk
Users might interpret aggregated self-reported data as medical advice to alter or stop their prescriptions, raising liability.
The Cold Start Data Problem
Without thousands of initial data points, specific 3-drug stack searches will return zero results, causing immediate churn.
Negative Reporting Bias
Patients only post when they have severe side effects, potentially skewing the database to look like all combinations cause extreme weight gain.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 7/10 against 2 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "analytics", "crowdsourcing", "data-management", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "PsychStack: Aggregated Side-Effect Insights for Psychiatric Polypharmacy" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for analytics?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.